Cargando…

Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas

The pathogenesis of ocular adnexal marginal zone lymphomas of mucosa-associated lymphatic tissue-type (OAML) is still poorly understood. We analyzed 63 cases of such lymphomas for non-synonymous mutations in 24 candidate genes by amplicon sequencing. We validated frequent mutations in the NF-κB regu...

Descripción completa

Detalles Bibliográficos
Autores principales: Johansson, Patricia, Klein-Hitpass, Ludger, Grabellus, Florian, Arnold, Georg, Klapper, Wolfram, Pförtner, Roman, Dührsen, Ulrich, Eckstein, Anja, Dürig, Jan, Küppers, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308752/
https://www.ncbi.nlm.nih.gov/pubmed/27566587
http://dx.doi.org/10.18632/oncotarget.11548
_version_ 1782507593023881216
author Johansson, Patricia
Klein-Hitpass, Ludger
Grabellus, Florian
Arnold, Georg
Klapper, Wolfram
Pförtner, Roman
Dührsen, Ulrich
Eckstein, Anja
Dürig, Jan
Küppers, Ralf
author_facet Johansson, Patricia
Klein-Hitpass, Ludger
Grabellus, Florian
Arnold, Georg
Klapper, Wolfram
Pförtner, Roman
Dührsen, Ulrich
Eckstein, Anja
Dürig, Jan
Küppers, Ralf
author_sort Johansson, Patricia
collection PubMed
description The pathogenesis of ocular adnexal marginal zone lymphomas of mucosa-associated lymphatic tissue-type (OAML) is still poorly understood. We analyzed 63 cases of such lymphomas for non-synonymous mutations in 24 candidate genes by amplicon sequencing. We validated frequent mutations in the NF-κB regulators MYD88, TNFAIP3 and TNIP1 in OAML, but also identified recurrent mutations in several additional components of the NF-κB pathway, including BCL10 and NFKBIA. Overall, 60% of cases had mutations in at least one component of NF-κB signaling, pointing to a central role of its genetic deregulation in OAML pathogenesis. Mutations in NOTCH1 and NOTCH2 were each found in 8% of cases, indicating a pathogenetic function of these factors in OAML. KMT2D was identified as the first epigenetic regulator with mutations in OAML, being mutated in 22% of cases. Mutations in MYD88 were associated with an inferior disease-free survival. Overall, we identified here highly recurrent genetic lesions in components of the NF-κB pathway, of NOTCH1 and NOTCH2 as well as KMT2D in OAML and thereby provide major novel insights into the pathogenesis of this B cell malignancy.
format Online
Article
Text
id pubmed-5308752
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-53087522017-03-09 Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas Johansson, Patricia Klein-Hitpass, Ludger Grabellus, Florian Arnold, Georg Klapper, Wolfram Pförtner, Roman Dührsen, Ulrich Eckstein, Anja Dürig, Jan Küppers, Ralf Oncotarget Research Paper The pathogenesis of ocular adnexal marginal zone lymphomas of mucosa-associated lymphatic tissue-type (OAML) is still poorly understood. We analyzed 63 cases of such lymphomas for non-synonymous mutations in 24 candidate genes by amplicon sequencing. We validated frequent mutations in the NF-κB regulators MYD88, TNFAIP3 and TNIP1 in OAML, but also identified recurrent mutations in several additional components of the NF-κB pathway, including BCL10 and NFKBIA. Overall, 60% of cases had mutations in at least one component of NF-κB signaling, pointing to a central role of its genetic deregulation in OAML pathogenesis. Mutations in NOTCH1 and NOTCH2 were each found in 8% of cases, indicating a pathogenetic function of these factors in OAML. KMT2D was identified as the first epigenetic regulator with mutations in OAML, being mutated in 22% of cases. Mutations in MYD88 were associated with an inferior disease-free survival. Overall, we identified here highly recurrent genetic lesions in components of the NF-κB pathway, of NOTCH1 and NOTCH2 as well as KMT2D in OAML and thereby provide major novel insights into the pathogenesis of this B cell malignancy. Impact Journals LLC 2016-08-23 /pmc/articles/PMC5308752/ /pubmed/27566587 http://dx.doi.org/10.18632/oncotarget.11548 Text en Copyright: © 2016 Johansson et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Johansson, Patricia
Klein-Hitpass, Ludger
Grabellus, Florian
Arnold, Georg
Klapper, Wolfram
Pförtner, Roman
Dührsen, Ulrich
Eckstein, Anja
Dürig, Jan
Küppers, Ralf
Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas
title Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas
title_full Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas
title_fullStr Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas
title_full_unstemmed Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas
title_short Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas
title_sort recurrent mutations in nf-κb pathway components, kmt2d, and notch1/2 in ocular adnexal malt-type marginal zone lymphomas
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308752/
https://www.ncbi.nlm.nih.gov/pubmed/27566587
http://dx.doi.org/10.18632/oncotarget.11548
work_keys_str_mv AT johanssonpatricia recurrentmutationsinnfkbpathwaycomponentskmt2dandnotch12inocularadnexalmalttypemarginalzonelymphomas
AT kleinhitpassludger recurrentmutationsinnfkbpathwaycomponentskmt2dandnotch12inocularadnexalmalttypemarginalzonelymphomas
AT grabellusflorian recurrentmutationsinnfkbpathwaycomponentskmt2dandnotch12inocularadnexalmalttypemarginalzonelymphomas
AT arnoldgeorg recurrentmutationsinnfkbpathwaycomponentskmt2dandnotch12inocularadnexalmalttypemarginalzonelymphomas
AT klapperwolfram recurrentmutationsinnfkbpathwaycomponentskmt2dandnotch12inocularadnexalmalttypemarginalzonelymphomas
AT pfortnerroman recurrentmutationsinnfkbpathwaycomponentskmt2dandnotch12inocularadnexalmalttypemarginalzonelymphomas
AT duhrsenulrich recurrentmutationsinnfkbpathwaycomponentskmt2dandnotch12inocularadnexalmalttypemarginalzonelymphomas
AT ecksteinanja recurrentmutationsinnfkbpathwaycomponentskmt2dandnotch12inocularadnexalmalttypemarginalzonelymphomas
AT durigjan recurrentmutationsinnfkbpathwaycomponentskmt2dandnotch12inocularadnexalmalttypemarginalzonelymphomas
AT kuppersralf recurrentmutationsinnfkbpathwaycomponentskmt2dandnotch12inocularadnexalmalttypemarginalzonelymphomas